Keyword: Wall Street Journal

News

Turing Chief Arrested for Securities Fraud

22.12.2015 - Martin Shkreli, CEO of Turing Pharma, which made headlines by raising the price of the 62-year-old drug, Daraprim (pyrimethamine) from $13.50 to $700 a tablet shortly after...

News

Shareholder Survey Calls for Syngenta Sale

21.12.2015 - A survey conducted by the Alliance of Critical Syngenta Shareholders has found that 79% of the 112 shareholders responding to the query support a sale of the company. The poll...

News

DuPont to Cut 10% of Staff Ahead of Dow Merger

17.12.2015 - On the heels of unveiling plans for their mega merger into a $130 million conglomerate before splitting into three parts, US chemical giants Dow and DuPont appear to be releasing...

News

AstraZeneca Confirms Talks with Acerta

15.12.2015 - AstraZeneca has confirmed speculation that it is “exploring potential strategic options” with Acerta Pharma, a privately owned biotech firm with operations in the Netherlands and...

News

Purported Dow-DuPont Merger Creates Buzz

10.12.2015 - News of a possible mega-merger between US chemical giants Dow and DuPont dominated the headlines on Dec. 9 after the newspaper Wall Street Journal, citing sources close to the...

News

Pfizer and Allergan in Merger Talks

30.10.2015 - US pharmaceutical giant Pfizer and Ireland-domiciled former US drugmaker Allergan (in its current incarnation a combined Allergan and Actavis) have confirmed they are in “friendly”...

News

Mallinckrodt Challenge Says FDA Overstepped Bounds

08.06.2015 - An unusual lawsuit claiming the Food and Drug Administration (FDA) overstepped its bounds by deciding that two generic drugs used to treat attention deficit hyperactivity disorder...

News

Endo International Tries to Spoil Valeant’s Salix Deal

16.03.2015 - Dublin, Ireland-based Endo International has made a takeover bid for US drugmaker Salix Pharmaceuticals in an effort to thwart Valeant Pharmaceuticals International's $10 billion...